XML 56 R39.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Accounting for Stock-Based Compensation (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2011
Mar. 31, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Dec. 31, 2010
Impact of Total Compensation Expense            
Effect on income from continuing operations before income taxes $ (10,814)   $ (10,655) $ (20,732) $ (20,418)  
Effect on net income (6,867)   (6,473) (13,165) (12,204)  
Fair value of stock options            
Expected volatility 38.10%   35.30% 31.50% 33.60%  
Expected dividends            
Expected term 4   3 4 3.1  
Risk-free interest rate 1.35%   1.20% 1.73% 1.47%  
Options outstanding and exercisable            
Beginning Balance, shares 8,503,393 7,834,332   7,834,332    
Granted, Shares 45,000 1,329,000        
Exercised, Shares (23,579) (595,431)        
Forfeited and cancelled, Shares (50,342) (64,508)        
Ending Balance, shares 8,474,472 8,503,393   8,474,472    
Beginning of Period, Weighted Average Exercise Price $ 33.10 $ 32.08   $ 32.08    
Granted, Weighted Average Exercise Price $ 28.12 $ 37.96   $ 28.12    
Exercised, Weighted Average Exercise Price $ 29.98 $ 30.44   $ 29.98    
Forfeited and cancelled, Weighted Average Exercise Price $ 32.70 $ 34.84        
End of Period, Weighted Average Exercise Price $ 33.08 $ 33.10   $ 33.08    
Weighted Average Remaining Contractual Term 5.8     5.8    
Aggregate Intrinsic Value 9,910     9,910    
Exercisable, Shares 5,804,556     5,804,556    
Exercisable, Weighted Average Exercise Price $ 32.78     $ 32.78    
Exercisable, Weighted Average Remaining Contractual Term 4.3          
Exercisable, Intrinsic Value 7,468     7,468    
Restricted stock outstanding            
Beginning Balance, Shares 2,247,578 2,125,291   2,125,291    
Granted, Shares 8,000 1,084,949        
Vested, Shares (12,000) (962,662)        
Forfeited, Shares            
Ending Balance, Shares 2,243,578 2,247,578   2,243,578    
Beginning of Period, Weighted Average Grant Date Fair Value $ 33.04 $ 27.92   $ 27.92    
Granted, Weighted Average Grant Date Fair Value $ 28.12 $ 37.96        
Vested, Weighted Average Grant Date Fair Value $ 33.49 $ 27.27        
Forfeited, Weighted Average Grant Date Fair Value            
End of Period, Weighted Average Grant Date Fair Value $ 33.02 $ 33.04   $ 33.02    
Deferred Director's Fee            
Directors' fees earned and deferred into plan $ 55   $ 45 $ 110 $ 90  
Share equivalent units 2,142   1,331 3,517 2,549